Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Promotie: Rol van CBX7 in regulatie bloedstamcellen
okt 2018 | Benigne hematologie, Leukemie